BILL ANALYSIS

HR4130

NEUTRAL

Small Business Relief Act

HR4130 (Small Business Relief Act) carries an AI-assessed market impact score of 4/10 with a neutral outlook for investors. This legislation directly affects $CME, $ICE and $NDAQ. The primary sectors impacted are Finance. View the full bill text on Congress.gov.

4/10

Impact Score

neutral

Market Sentiment

3

Affected Stocks

1

Sectors Impacted

Key Takeaways for Investors

1

HR4130 aims to delay mandatory public registration for private companies by excluding institutional investors from holder counts.

2

The bill provides regulatory relief, not direct financial aid or appropriations.

3

Impact on exchange operators like $CME, $ICE, and $NDAQ is indirect, potentially affecting the IPO pipeline over the long term.

4

The bill has active legislative momentum, having been reported out of committee and placed on the Union Calendar.

How HR4130 Affects the Market

The 'Small Business Relief Act' (HR4130) is designed to allow private companies to remain private for longer by adjusting the mandatory public registration thresholds. This could subtly impact the long-term pipeline of initial public offerings (IPOs) for exchange operators. While a reduced IPO pipeline might be a minor headwind, the current market data for $CME, $ICE, and $NDAQ shows positive 7-day performance, with $CME up +5.25%, $ICE up +6.12%, and $NDAQ up +2.32%. These movements are likely driven by broader market factors rather than immediate reactions to HR4130, given its indirect and long-term nature of impact. The bill's effect on these tickers is more structural regarding future market activity rather than immediate financial performance.

Bill Details

MetricValue
Bill NumberHR4130
Impact Score4/10Certainty: Floor action (+0.3 velocity (9 actions)) · Financial Magnitude: No explicit funding identified · Strategic Weight: AI qualitative assessment: 4/10 · Market Penetration: 3 companies directly affected
Market Sentimentneutral
Event Date
Affected SectorsFinance
Affected Stocks$CME, $ICE, $NDAQ
SourceView on Congress.gov →

Summary

HR4130, the Small Business Relief Act, aims to reduce regulatory burdens for private companies by amending registration thresholds, potentially delaying their public market entry. This bill does not provide direct financial aid or tax incentives. The immediate market impact is minimal, but it affects the pipeline for future IPOs, which could subtly influence exchange operators like CME Group Inc. ($CME), Intercontinental Exchange, Inc. ($ICE), and Nasdaq, Inc. ($NDAQ) over the long term.

Full AI Market Analysis

HR4130, titled the Small Business Relief Act, was placed on the Union Calendar, Calendar No. 450, on 2026-02-25, indicating it has been reported out of committee and is awaiting floor consideration in the House. The bill was reported (Amended) by the Committee on Financial Services on the same day. The core of the bill amends Section 12(g)(1) of the Securities Exchange Act of 1934 to exclude qualified institutional buyers and institutional accredited investors when calculating holders of a security for purposes of the mandatory registration threshold. This effectively raises the bar for private companies to be forced into public registration, allowing them to remain private for longer. This legislation does not involve direct funding or appropriations. Instead, it offers regulatory relief by adjusting the criteria for mandatory public registration. The mechanism is a change in how 'holders of a security' are counted, specifically excluding sophisticated institutional investors from that count. This means that private companies can attract capital from these large investors without triggering the requirement to go public, thereby extending their private growth phase. There is no money trail in terms of government spending; rather, it is a structural change to market entry regulations. Structural winners from this bill, if enacted, would be private companies that wish to delay their public market entry, as they gain more flexibility in their capital raising strategies. The impact on publicly traded exchange operators like CME Group Inc. ($CME), Intercontinental Exchange, Inc. ($ICE), and Nasdaq, Inc. ($NDAQ) is indirect. While these exchanges profit from IPOs and subsequent trading, a delay in IPOs could marginally reduce their pipeline of new listings over time. However, the current market data for these tickers shows mixed performance: $CME is up +5.25% over 7 days, $ICE is up +6.12% over 7 days, and $NDAQ is up +2.32% over 7 days. All three are trading well within their 52-week ranges, with $CME at $310.87, $ICE at $166.92, and $NDAQ at $86.86. The recent positive 7-day performance for all three suggests that this legislative development is not currently a primary driver of their stock movements. The next legislative step for HR4130 is consideration on the House floor, as it has been placed on the Union Calendar. Given its recent reporting out of committee and placement on the calendar, the bill shows active momentum. The sponsor, Rep. Garbarino, is a Republican from New York, and the bill has one cosponsor. The bill was referred to the Committee on Financial Services, which reported it favorably. The bill's progress indicates it is moving through the legislative process, but it still requires a House vote, Senate consideration, and presidential assent to become law.

Stocks Affected by HR4130

Sectors Impacted by HR4130

Related Finance Legislation

Understand the Terms

Track Bills Like HR4130 Daily

Get AI-analyzed alerts when Congress moves markets.

Get Started →